What are the chances that what allegedly happened with GlaxoSmithKline’s Chinese operations are also going on elsewhere? Pretty high. Is money laundering taking place inside your company? Would you know? A robust third party risk management program would have gone a long way in detecting – or even preventing – the GSK scandal by identifying potential third party red flags related to the travel agencies implicated. Based on emerging details of the GSK investigation, we will share some early lessons and questions to help your organization do a little preventative soul searching.